Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Total Liabilities: 2013-2024

Historic Total Liabilities for KalVista Pharmaceuticals (KALV) over the last 9 years, with Apr 2024 value amounting to $28.8 million.

  • KalVista Pharmaceuticals' Total Liabilities was N/A to $130.5 million in Q4 2024 from the same period last year, while for Dec 2024 it was $130.5 million, marking a year-over-year change of. This contributed to the annual value of $28.8 million for FY2024, which is N/A change from last year.
  • KalVista Pharmaceuticals' Total Liabilities amounted to $28.8 million in FY2024, which was up 228.38% from $8.8 million recorded in FY2020.
  • In the past 5 years, KalVista Pharmaceuticals' Total Liabilities registered a high of $28.8 million during FY2024, and its lowest value of $8.8 million during FY2020.
  • Moreover, its 1-year median value for Total Liabilities was $28.8 million (2024), whereas its average is $28.8 million.
  • Data for KalVista Pharmaceuticals' Total Liabilities shows a maximum YoY tumbled of 58.97% (in 2020) over the last 5 years.
  • Yearly analysis of 2 years shows KalVista Pharmaceuticals' Total Liabilities stood at $8.8 million in 2020, then followed by $28.8 million in 2024.